Skip to main content
Log in

Pneumatic trabeculoplasty a new method to treat primary open-angle glaucoma and reduce the number of concomitant medications

  • Original Article
  • Published:
Annals of Ophthalmology

Abstract

Pneumatic trabeculoplasty (PNT), when used in combination with antiglaucoma medication, was evaluated in two studies: a feasibility study involving 177 patients, and a separate efficacy study involving 317 eyes. Both studies were nonblinded, single-armed, and nonrandomized; the primary efficacy end point in each study was a decrease in intraocular pressure (IOP) compared with baseline. The first study reported a mean drop in IOP of 6.3 mmHg across the entire group. The second study showed a mean IOP after PNT treatment level at least 1 mmHg less than the pretreatment mean; except at 3, 6, 9, and 12 months, when it was at least 2 mmHg less than the initial mean IOP. The lesser reduction observed in the second study can be explained by the fact that a number of the patients were at least partially controlled by antiglaucoma medications at enrollment, and, as a result, the group had a lower starting IOP than those enrolled in the first study. In both studies, a clear trend to less medication was observed when PNT was added to a patient’s treatment regime. The ability of PNT to reduce IOP and medication requirements, along with its relatively benign safety profile, supports the use of PNT as part of a glaucoma patient’s treatment regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sommer A, Tielsch JM, Katz, J., et al. Racial differences in the causespecific prevalence of blindness in east Baltimore [see comments]. N Engl J Med. 1991;325:1440–1442.

    Article  Google Scholar 

  2. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:166–191.

    PubMed  CAS  Google Scholar 

  3. Society to Prevent Blindness (NSPB). Vision Problems in the U.S. National Society to Prevent Blindness. New York, 1980.

  4. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134:1102–1110.

    PubMed  CAS  Google Scholar 

  5. Quigley HA. Open-angle glaucoma [see comments]. N Engl J Med. 1993;328:1097–1106.

    Article  PubMed  CAS  Google Scholar 

  6. Schappert SM. National Center for Health Statistics. Office visits for glaucoma: United States, 1991–92. Advance Data from Vital and Health Statistics of the Centers for Disease Control and Prevention; No 262; 1995.

  7. Grant WM, Burke JF, Jr. Why do some people go blind from glaucoma? Ophthalmol. 1982;89:991–998.

    CAS  Google Scholar 

  8. Kahn HA, et al. The Framingham Eye Study. I. Outline and major prevalance findings. Am J Epidemiol. 1977;106:17–32.

    PubMed  CAS  Google Scholar 

  9. Kahn HA et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106; 33–41.

    PubMed  CAS  Google Scholar 

  10. Office of Technology Assessment, Congress of the United States. Screening for open-angle glaucoma in the elderly. 1988

  11. Kass MA, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol. 1989;107:1590–1598.

    PubMed  CAS  Google Scholar 

  12. Epstein DL, et al. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects [see comments]. Ophthalmol. 1989;96:1460–1467.

    CAS  Google Scholar 

  13. Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects [see comments]. Ophthalmol. 1991;98: 301–307.

    CAS  Google Scholar 

  14. Lundberg L, Wettrell K, Linner E. Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol (Copenh). 1987; 65:705–708.

    Article  CAS  Google Scholar 

  15. Hovding G, Aasved H. Prognostic factors in the development of manifest open angle glaucoma. A long-term follow-up study of hypertensive and normotensive eyes. Acta Ophthalmol (Copenh). 1986;64:601–608.

    CAS  Google Scholar 

  16. Spooner JJ, Bullano MF, Ikeda LI, et al. Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care. August 2002;S262–270.

  17. Harris J, et al. Determination of the efficacy and mechanism of action for pneumatic trabeculoplasty in the treatment of open-angle glaucoma. Invest Ophthalmol Vis Sci. 1998;39:Abstract 574.

    Google Scholar 

  18. Barraquer JI. Cirugia Refractiva de la Cornea: Historia de la cirugia refractiva de la cornea. Vol. 1. Instituto Barraquer de America, Bogota, Columbia, 1989:pp. 5–64.

    Google Scholar 

  19. Bores LD. Refractive Eye Surgery. Blackwell’s Scientific Publications. Cambridge, England, 1992.

    Google Scholar 

  20. Sachs HG, Lohmann CP, Op de Laak JP. Intraocular pressure in sections with 2 microkeratomes in vitro]. Ophthalmologe. 1997; 94:707–709.

    Article  PubMed  CAS  Google Scholar 

  21. Kim HM, Jung HR. Laser assisted in situ keratomileusis for high myopia. Ophthalmic Surg Lasers. 1996;27(5 Suppl):S508-S511.

    PubMed  CAS  Google Scholar 

  22. Ozdamar A, et al. Bilateral retinal detachment associated with giant retinal tear after laser-assisted in situ keratomileusis. Retina. 1998; 18:176–177.

    Article  PubMed  CAS  Google Scholar 

  23. Rodriguez A, Camacho H. Retinal detachment after refractive surgery for myopia. Retina 1992;12(3 Suppl):S46-S50.

    Article  PubMed  CAS  Google Scholar 

  24. Shepard DD. Intraocular lens implantation—analysis of 500 consecutive cases. Ophthalmic Surg. 1977;8:57–63.

    PubMed  CAS  Google Scholar 

  25. Gürses-Özden R, Liebmann JM, Schuffner D, et al. Retinal nerve fiber layer thickness remains unchanged following laser-assisted in situ keratomileusis. Am J Ophthalmol. 2001;132:512–516.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leo D. Bores MD.

Additional information

Drs. Leo D. Bores and John T. LiVecchi have stated that they do have significant financial interest or other relationship with a product manufacturer or for Ophthalmic International and (Dr. LiVecchi is Medical Director and a member of the Board of Directors of Coronado Industries). Dr. Guillermo Avalos Urzúa has no financial interest the device. The authors also do discuss the use of off-label products, which includes unlabeled, unapproved, or investigative devices.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urzúa, G.A., Bores, L.D. & Livecchi, J.T. Pneumatic trabeculoplasty a new method to treat primary open-angle glaucoma and reduce the number of concomitant medications. Ann Ophthalmol 37, 37–46 (2005). https://doi.org/10.1385/AO:37:1:037

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/AO:37:1:037

Keywords

Navigation